DLK1 and embryonal rhabdomyosarcoma: Since distinguishing between ARMS and ERMS currently requires histopathology analysis of patient samples, we developed methylation-specific PCR primers that enable quick and specific analysis of the methylation status of the DLK1-GTL2 locus and thus can be potentially employed in RMS diagnostics (Fig. 1D).